The Biomedical Advanced Research and Development Authority (BARDA) reopened submissions for redeveloping therapeutics into medical countermeasures against chemical threats last week. Of interest are therapeutics already approved by the U.S. Food and Drug Administration (FDA) or those in late-stage development. ... Read More » The post BARDA reopens abstract submissions in search of repurposed therapeutics for DRIVe ReDIRECT program appeared first on Homeland Preparedness News.
